Case File
efta-01760006DOJ Data Set 10OtherEFTA01760006
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01760006
Pages
4
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Sent:
Monday, May 6, 2013 6:05 PM
To:
Jeffrey Epstein
Subject:
Fwd: Proposed SC investment framework - revised
What's your view?
Thanks
=br>
Begin forwarded message:
From: Ramesh Venkataraman
<mailto
>
Date: 4 May 2=13 20:09:18 GMT+03:00
To:
<mailt
Subject: Proposed SC investment fr=mework - revised
David,
Good to see you yesterd=y!
Following our discussions on April 19, I have modified the p=oposed structure for the situation where a liquidity
event happens after=the next capital raising round or the 18 month anniversary of the date of t=e SC investment (the
structure for a liquidity event happening sooner r=mains the same as in the email below). Let me know if this revi=ed
proposal is more in line with your thinking:
Exit EV 'waterfall'=/p> Samena % of exit proceeds<=:p>
Sm
=p class="MsoNormal">%
50%
50 to 100
30%
500 to Slb
EFTA_R1_00064117
EFTA01760006
5%
Above $lb<=o:p>
3%
What this means is as follows:
*&=bsp;
if the EV at exit is at or below $50 mn, then Samena's return= are the same as the previous
proposal. This, if EV is $50 mn, we wil= get 50% of the amount over that owed to Informa. If the Informa loan=note
principal + accrued interest repayment obligation is $24 mn, then Same=a gets $13 mn and the other common equity
holders get $13 mn.
•
= If the EV at exit is $80 mn, then=SC gets $21 mn whereas in the previous proposal we would have got $38
mn.&n=sp;
•
&nbs=; If EV at exit is $12= mn, then SC gets $30 mn, whereas in the previous proposal we would have go=
$42 mn
c=pan style="font-family:Symbol">• &=bsp; If the exit is at=a blockbuster EV of $500M, SC gets $68 mn vs
$118M previously </=:p>
1= addition, I wanted to confirm our institutional (and my personal) commitme=t to assisting you and AG in the
next round of capital raising (while, of c=urse, in no way implying any financial commitment from Samena to
participat=). Amongst other things, this will include help on capital raising st=ategy, IM and investor presentation
preparation and adviser selection. =
The rest of the proposal remains the same as below (eg, we need to w=rk out governance etc).
&n=sp;
We were originally targeting mid-May fo= the team to be in Beijing. From a Poseidon perspective, the best t=me
for me would be post May 25 although I could conceivably squeeze in a co=ple of days around May 15-19. Let me know.
From: David,
Hope your trip to Ch=na is going well. Apologies that it has taken me a week to follow up o= our discussions.
Have been swamped on a number of fronts including a= unexpected (but hopefully positive) turn of events on Poseidon
— w=ll brief you on your return from China.
Here is a proposed fram=work that I have developed for your review/comment. Let me have your t=oughts
either via email or, if you prefer, we can wait until your return to=discuss in person.
</=>
2
EFTA_R1_00064118
EFTA01760007
1. &nbs=; Subject to confirmatory diligence (expe=ted to take no more than 2-3 weeks) and final
documentation, SC will invest=$5 million in July 2013 or as soon as AG receives the first RMB 1 mn from C=engdu. As
discussed, this $5 million amount will be the only fu=ding commitment from SC to AG (and this should be documented
and minuted by=AG for the avoidance of doubt/misconception). However, as discussed, w= are fully committed to
assisting you/AG in future rounds of capital raisin= from other investors including tapping the Samena network.
=nbsp; Our instrument will be struct=red as preference shares (zero coupon) convertible into common equity
upon a=liquidity event (IPO, trade sale, partial divestment).
3.
= Our instrument will presumably rank behi=d the Informa $16 mn loan note from 2010 (payable in 2020
with a 10% roll u= coupon) and only be payable after that loan note principal and accrued int=rest are paid out. We can
refine our structure once we have access to= the loan note docs and understand the draw down schedule and payment
o=ligations.
4.&nb=p;
The conversion=ratio for our instrument into equity shares will be on the basis of a liqui=ity
preference table as follows:
c.<=pan style="font:7.Opt "Times New Roman""> &nbs=; Balance $21.5 mn to be split acro=s the remaining
common equity holders in proportion to their shareholding %=o:p>
B.
If a liquidit= event happens after the next capital raising round or the 18 month anni=ersary of the date of
the SC investment:
Exit EV lwaterfall'</=:p>
Samena % of exit pr=ceeds
Sm
50%
100 to 500=/p
=00 plus
5.
Any=new investor in a subsequent round (say in 2014) buys into the equity in a n=rmal way, ie, the
board sets a pre-money valuation for the equity etc. = The SC prefs do not get diluted — ie, the conversion framework
out=ined above stays the same.
6. &=bsp; Other terms can be worke= out, eg, negative covenants, board seats, IPO secondary offering rights, e=c. It is
also going to be critical to discuss how AG's burn r=te can be reduced — ideally cut below $700K p.m., so our investment
plus the $6M of cash that AG has curre=tly can last at least 18 months just in case of the inevitable execution de=ays in
Chengdu.
3
EFTA_R1_00064119
EFTA01760008
David, ple=se treat this as a draft for discussion that we can refine over the next fe= days based on your feedback to
arrive at a mutually acceptable framework.<=:p>
Best
Ramesh
</=iv>
4
EFTA_R1_00064120
EFTA01760009
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.